Black widow spider antivenin (equine)

DB14113ApprovedProtein Based TherapiesAntivenins

Black widow spider (Latrodectus mactans) antivenin is a treatment for black widow spider bites derived from the serum of healthy horses immunized against black widow spider venom.

First approval
United States, 1947
Also known as
Antivenin (latrodectus mactans) · Antivenin (latrodectus mactans) (equine) · Antivenin, latrodectus mactans · Antivenin, latrodectus mactans, equine · Antivenin,latrodectus mactans

Resolves to

Compound
UNII5VJA14972G
Clinical / RWD
RxNorm89887

What you can answer from here — as of May 12, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 1 country and 1 labeller
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Black widow spider antivenin (equine), and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In